Results from Gencor’s recent human clinical study support its palmitoylethanolamide (PEA) ingredient, Levagen+, to be a safe and effective supplement for easing acute menstrual discomfort.Preclinical research suggests that PEA’s primary mechanism of action provides relief from occasional discomfort and supports a balanced inflammatory response, which may be through the activation of peroxisome proliferator-activated receptor-α (PPAR α).
